COVID-19: Clinical features
K McIntosh, MS Hirsch, A Bloom - Uptodate Version, 2021 - uptodate.com
Coronaviruses are important human and animal pathogens. At the end of 2019, a novel
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …
Systematic review and meta-analyses of the interaction between HIV infection and COVID-19: two years' evidence summary
Introduction During the COVID-19 pandemic, people living with HIV (PLWH) were
considered to be at risk of worse COVID-19 outcomes once infected. However, the existing …
considered to be at risk of worse COVID-19 outcomes once infected. However, the existing …
[HTML][HTML] Lymphopenia as a predictor for adverse clinical outcomes in hospitalized patients with COVID-19: a single center retrospective study of 4485 cases
J Niu, C Sareli, D Mayer, A Visbal, A Sareli - Journal of Clinical Medicine, 2022 - mdpi.com
JCM | Free Full-Text | Lymphopenia as a Predictor for Adverse Clinical Outcomes in
Hospitalized Patients with COVID-19: A Single Center Retrospective Study of 4485 Cases …
Hospitalized Patients with COVID-19: A Single Center Retrospective Study of 4485 Cases …
Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020.
AE Shapiro, RAB Ignacio, BM Whitney… - JAIDS Journal of …, 2022 - journals.lww.com
Background: Understanding the spectrum of COVID-19 in people with HIV (PWH) is critical
to provide clinical guidance and risk-reduction strategies. Setting: CNICS, a US multisite …
to provide clinical guidance and risk-reduction strategies. Setting: CNICS, a US multisite …
COVID-19 vaccine hesitancy and associated factors among people with HIV in the United States: findings from a national survey
Introduction: Scaling up vaccination against COVID-19 is central to controlling the COVID-19
epidemic in the United States. Several vaccines are now approved for the prevention of …
epidemic in the United States. Several vaccines are now approved for the prevention of …
Social and behavioral impacts of COVID-19 on people living with HIV: review of the first year of research
SC Kalichman, R El-Krab - Current HIV/AIDS Reports, 2022 - Springer
Abstract Purpose of the Review The SARS-CoV-2 (COVID-19) pandemic brought
unprecedented social change with the most severe impacts on the most vulnerable …
unprecedented social change with the most severe impacts on the most vulnerable …
Impact on HIV-1 RNA levels and antibody responses following SARS-CoV-2 vaccination in HIV-infected individuals
V Portillo, C Fedeli, P Ustero Alonso, I Petignat… - Frontiers in …, 2022 - frontiersin.org
This study aims to assess the immunological response and impact on virological control of
the mRNA vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
the mRNA vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Factors associated with SARS-CoV-2-related hospital outcomes among and between persons living with and without diagnosed HIV infection in New York State
EM Rosenthal, ES Rosenberg, W Patterson… - PLoS …, 2022 - journals.plos.org
Background Persons living with diagnosed HIV (PLWDH) are at increased risk for severe
illness due to COVID-19. The degree to which this due to HIV infection, comorbidities, or …
illness due to COVID-19. The degree to which this due to HIV infection, comorbidities, or …
Expert consensus: main risk factors for poor prognosis in COVID-19 and the implications for targeted measures against SARS-CoV-2
FJ Candel, P Barreiro, M Salavert, A Cabello… - Viruses, 2023 - mdpi.com
The clinical evolution of patients infected with the Severe Acute Respiratory Coronavirus
type 2 (SARS-CoV-2) depends on the complex interplay between viral and host factors. The …
type 2 (SARS-CoV-2) depends on the complex interplay between viral and host factors. The …
[HTML][HTML] Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance
M Leston, W Elson, JM Ordóñez-Mena, D Kar… - Journal of Infection, 2024 - Elsevier
Background Effective disease surveillance, including that for COVID-19, is compromised
without a standardised method for categorising the immunosuppressed as a clinical risk …
without a standardised method for categorising the immunosuppressed as a clinical risk …